http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004517900-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F5-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B61-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 |
| filingDate | 2001-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2004517900-A |
| titleOfInvention | Method for synthesizing intermediate compound atorvastatin form V and phenylboronic acid |
| abstract | The present invention relates to R- (R * , R * )]-2- (4-fluorophenyl) -B, D-dihydroxy-5- (1-methylethyl) -3-phenyl-4-[(phenylamino) A novel method for synthesizing hemicalcium, carbonyl] -1H-pyrrole-1-heptanate, atollstatin Form V is discussed. This compound is useful as an inhibitor of the enzyme HMG-CoA reductase, and is therefore useful as an antihyperlipidemic and antihypercholesterolemic drug. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008510798-A |
| priorityDate | 2001-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 136.